Evidence map›Paper›PMID 31820023›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2020

Elevated urinary IL-1β levels in multidrug resistant Escherichia coli and Klebsiella infections.

Priya Kannian, Veeraraghavan Ashwini, Sitaraman Balasubramanian Suchithra, Krishnaraj Buvaneshwari Sindu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Human neutrophil peptides 1-3 protect the murine urinary tract from uropathogenicProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Priya KannianDepartment of Clinical Research, VHS Hospital, Rajiv Gandhi Salai, Taramani, Chennai, 600113, Tamil Nadu, India. priyakannian@gmail.com.ORCID http://orcid.org/0000-0002-2790-6676
Veeraraghavan AshwiniDepartment of Clinical Research, VHS Hospital, Rajiv Gandhi Salai, Taramani, Chennai, 600113, Tamil Nadu, India.
Sitaraman Balasubramanian SuchithraDepartment of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamil Nadu, India.
Krishnaraj Buvaneshwari SinduDepartment of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamil Nadu, India.
Rajalakshmi Engineering CollegeVoluntary Health Services Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMultidrug resistant (MDR) E. coli and Klebsiella infections are rising. IL-1β has been implicated in the differentiation of symptomatic and asymptomatic urinary tract infections, but its role in MDR infections has not been elucidated. MATERIAL AND

methodsUrinary IL-1β levels were analysed by ELISA.

resultsUrinary IL-1β levels were statistically higher in patients with bacterial burden compared to controls and also in patients with MDR bacterial infections compared to those with multidrug-sensitive bacterial infections.

conclusionsUrinary IL-1β levels might be a useful tool to identify patients with challenging MDR bacterial infections.

Indexed as

Drug Resistance, Multiple, BacterialBiomarkersEscherichia coliEscherichia coli InfectionsHumansInterleukin-1betaKlebsiellaKlebsiella InfectionsBiomarkersIL1B protein, humanInterleukin-1betaE. coliIL-1βKlebsiellaMultidrug resistantUrinary tract infections

Identifiers

PMID31820023
OpenAlexW2992497068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.